Inhibiting Effect of Medical Compounds for SARS-CoV-2 and Secretory Phospholipase A2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibiting Effect of Medical Compounds for SARS-CoV-2 and Secretory Phospholipase A2

Published:2023-01-15 Issue:1 Volume:15 Page:5-8
ISSN:1996-5052
Container-title:Current Research in Chemistry
language:
Short-container-title:Current Research in Chemistry

Author:

Gökal Faik^ORCID

Publisher

Science Alert

Subject

General Medicine

Link

https://www.scialert.net/fulltext/?doi=crc.2023.5.8

Reference15 articles.

1. Estimation of the Phospholipase A2 Selectivity on POPC/POPG Membranes Using the Interaction Map

2. Expression of Secretory Phospholipase A2 Group IIa in Breast Cancer and Correlation to Prognosis in a Cohort of Advanced Breast Cancer Patients

3. Secretory Phospholipase A2 Enzymes in Acute Lung Injury

4. Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C)

5. Naturally occurring biflavonoid, ochanflavone, inhibits cyclo-oxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3